The company's active pharmaceutical ingredient (API) plant is located in Nanjing Chemical Industrial Park, covering an area of 45 mu (approximately 3 hectares). It has four production workshops and can produce more than 10 products annually, such as levamisole hydrochloride, ketoconazole, calcium ketoglutarate, and chloramphenicol, according to market demand, with an annual production capacity exceeding 1000 tons. The plant's production facilities, process layout, purified water system, and purification system are all at the leading level among similar enterprises.

　　The company has more than 40 years of experience in API manufacturing, with mature and stable production processes. Since its restructuring, the company has adopted a strategy of "specializing in advantageous APIs and focusing on the development of specialty APIs." It has strengthened internal management and focused on external cooperation. Currently, there are 15 new APIs under research and development.

　　In order to improve the comprehensive level of API production management, and to demonstrate the company's ability to provide high-quality products and bring APIs to the US market, in 2008, the company decided to invest in the construction of a high-end API workshop according to FDA hardware standards. The workshop was completed and put into production of levamisole hydrochloride in 2009. In 2011, it successfully passed the FDA's on-site audit and was listed as "acceptable." In September 2014, levamisole hydrochloride passed the European CEP certification, successfully expanding into the high-end European market. In April 2015, it received written approval from the US FDA on-site audit, and levamisole products have been approved for legal sales in relevant controllable industries in the United States.

　　In terms of safety and environmental protection in API production, the company has made a pledge of "rather stop production than pollute and harm people." Aiming to be a leader in environmental protection, the company has invested over 18 million yuan in the construction and renovation of environmental protection facilities since 2009, with environmental operation costs exceeding 20 million yuan. Advanced wastewater and waste gas treatment equipment has been repeatedly commended by the municipal environmental protection bureau.

　　The company's levamisole hydrochloride products account for more than 50% of the global market share; ketoconazole production and sales are leading in China, accounting for more than 60% of the domestic market share. The company will cooperate through multiple channels, keep up with the development trends of the international pharmaceutical industry, seize more opportunities, and achieve better development.

Garden Factory

Plant Gate	Plant Avenue	Standing Tall
Tree-lined Avenue	Shining Together	Tropical Scenery

Plant Scenery

Welcome Slogan	Comprehensive Building	Workshop Lobby
Strict System	Finished Product Warehouse	Workshop Corridor

Corporate Culture

Friendly Reminder	Safety and Happiness	Constant Warning
Strict Management	Social Responsibility	Entrance Requirements

Landscape Features

Vivid Colors	Fragrant Within the Walls	Deep Courtyard
Leisure Pavilion	Whale Playing in Water	Colorful and Vibrant

Overlooking Bai Jingyu

Wastewater Treatment	Environmental Protection Tower	Mansion Compound
Red Flags Flying